0001214659-19-002039.txt : 20190311
0001214659-19-002039.hdr.sgml : 20190311
20190311175314
ACCESSION NUMBER: 0001214659-19-002039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190308
FILED AS OF DATE: 20190311
DATE AS OF CHANGE: 20190311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Durrant Cameron
CENTRAL INDEX KEY: 0001421882
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35798
FILM NUMBER: 19673324
MAIL ADDRESS:
STREET 1: 90, FAIRMOUNT ROAD WEST
CITY: CALIFON
STATE: NJ
ZIP: 07830-3330
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HUMANIGEN, INC
CENTRAL INDEX KEY: 0001293310
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770557236
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 200
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650.243.3100
MAIL ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 200
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20040609
4
1
marketforms-44553.xml
PRIMARY DOCUMENT
X0306
4
2019-03-08
0001293310
HUMANIGEN, INC
HGEN
0001421882
Durrant Cameron
C/O HUMANIGEN, INC.
533 AIRPORT BOULEVARD, SUITE 400
BURLINGAME
CA
94010
true
true
false
false
Chief Executive Officer
Common Stock, $0.001 par value
2019-03-08
4
A
false
75000
0.665
A
238583
D
Employee Stock Option Exercise (Right to Buy)
0.665
2019-03-08
4
M
false
75000
0
D
2018-03-09
2026-09-12
Common Stock
75000
8434771
D
These stock options were granted to the executive on March 9, 2018 to preserve the incentive offered to the executive in connection with his stock option granted on September 13, 2016, after giving effect to the dilution resulting from the completion of the Company's previously reported restructuring transaction on February 27, 2018. Accordingly, the option was deemed vested as to one-half of the underlying shares as of the grant date, with the remainder vesting in six quarterly installments commencing June 13, 2018.
/s/ Deborah Brown, Attorney-In-Fact
2019-03-11